Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTomco Energy Regulatory News (TOM)

Share Price Information for Tomco Energy (TOM)

Share Price is delayed by 15 minutes
Get Live Data
0.0265    -0.0025 (-8.62%)
Bid:
0.026
Ask:
0.027
Spread: 0.001 (3.846%)
Market Cap: £1.60m
TOM Live PriceLast checked at - London Stock Exchange

Intraday Tomco Energy Share Chart

Quadrise Testing Update

23 Sep 2021 07:30

RNS Number : 6878M
TomCo Energy PLC
23 September 2021
 

23 September 2021

TOMCO ENERGY PLC

("TomCo" or the "Company")

 

Quadrise Testing Update

TomCo Energy plc (AIM: TOM), the US operating oil development group focused on using innovative technology to unlock unconventional hydrocarbon resources, is pleased to note the announcement made earlier today by Quadrise Fuels International plc ("Quadrise") providing an update on its testing of a produced oil sample supplied by TomCo's 100% owned subsidiary Greenfield Energy LLC ("Greenfield") taken from the Petroteq Oil Sands Plant ("POSP") during Greenfield's operation of the POSP.

Quadrise has reported that an extensive programme of testing on the Greenfield oil sample was completed at the Quadrise Research Facility ("QRF") in Essex on schedule, and a report has now been issued to Greenfield.

Quadrise noted that the ability to produce commercial MSAR® and bioMSAR™ fuels from the produced oil has been confirmed from its testing. Simulations of storage and handling of both fuels were also completed during the programme. The testing at the QRF confirmed the suitability of the heavy sweet oil for the commercial production of MSAR® and bioMSAR™ fuels in Utah for potential power and marine end-user applications domestically and internationally.

Quadrise further noted that this testing concludes the proof-of-concept work that was scheduled in Phase 1 of the Commercial Trial Agreement between Greenfield and Quadrise announced on 18 August 2020. TomCo will now review the report and it is expected that Greenfield and Quadrise will enter into discussions regarding potential future trials and deployment of the technology to produce MSAR® and/or bioMSAR™ fuel at a commercial scale.

Commenting, John Potter, CEO of TomCo, said: "We are delighted that Quadrise has now completed its testing programme. We are encouraged by the positive confirmations issued by Quadrise today and we look forward to continuing to work with Quadrise as we progress our plans for Greenfield."

 

Enquiries:

 

TomCo Energy plc

Malcolm Groat (Chairman) / John Potter (CEO) +44 (0)20 3823 3635

Strand Hanson Limited (Nominated Adviser)

James Harris / Matthew Chandler +44 (0)20 7409 3494

Novum Securities Limited (Broker)

Jon Belliss / Colin Rowbury +44 (0)20 7399 9402

IFC Advisory Limited (Financial PR)

Tim Metcalfe / Florence Chandler +44 (0)20 3934 6630

For further information, please visit www.tomcoenergy.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAFNAALEFEAA
Date   Source Headline
19th Aug 20229:00 amRNSPrice Monitoring Extension
16th Aug 20224:40 pmRNSSecond Price Monitoring Extn
16th Aug 20224:35 pmRNSPrice Monitoring Extension
1st Aug 20227:00 amRNSFurther Extension of Valkor Loan
15th Jul 20227:00 amRNSGranting of Utah Tax Credit to Greenfield
7th Jul 20223:30 pmRNSResult of AGM
28th Jun 20227:00 amRNSInterim Results
28th Jun 20227:00 amRNSFurther Extension of Valkor Loan Repayment Terms
14th Jun 20223:17 pmRNSHolding(s) in Company
14th Jun 20227:00 amRNSNotice of AGM
31st May 20227:00 amRNSGreenfield Update
1st Apr 20227:00 amRNSResults for the year ended 30 September 2021
10th Mar 20227:00 amRNSTSHII Lease Agreement with Vivakor
10th Feb 20227:00 amRNSTSHII Update
9th Feb 20222:34 pmRNSHolding(s) in Company
8th Feb 20222:41 pmRNSHolding(s) in Company
7th Feb 20225:21 pmRNSHolding(s) in Company
7th Feb 20222:07 pmRNSHolding(s) in Company
1st Feb 20224:26 pmRNSHolding(s) in Company
1st Feb 20224:02 pmRNSHolding(s) in Company
1st Feb 20224:01 pmRNSHolding(s) in Company
31st Jan 20221:08 pmRNSHolding(s) in Company
31st Jan 202212:43 pmRNSHolding(s) in Company
28th Jan 20222:46 pmRNSHolding(s) in Company
27th Jan 20221:40 pmRNSHolding(s) in Company
26th Jan 20227:00 amRNSServices Agreement with Heavy Sweet Oil
25th Jan 20227:00 amRNSWaiver of Options
24th Jan 202211:05 amRNSSecond Price Monitoring Extn
24th Jan 202211:01 amRNSPrice Monitoring Extension
24th Jan 20227:00 amRNSPlacing, Directorate Changes & Operational Update
13th Jan 20227:00 amRNSReserves Report for TSHII Site
4th Jan 20224:41 pmRNSSecond Price Monitoring Extn
4th Jan 20224:36 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSWarrant Exercise
16th Nov 20217:00 amRNSAcquisition of an initial 10% interest in TSHII
29th Sep 20217:00 amRNSFurther Update re TSHII
27th Sep 20214:40 pmRNSSecond Price Monitoring Extn
27th Sep 20214:35 pmRNSPrice Monitoring Extension
23rd Sep 20217:30 amRNSQuadrise Testing Update
8th Sep 20214:50 pmRNSResult of AGM
8th Sep 20214:41 pmRNSSecond Price Monitoring Extn
8th Sep 20214:35 pmRNSPrice Monitoring Extension
8th Sep 20217:00 amRNSAGM Statement
1st Sep 20217:00 amRNSTSHII Update
26th Aug 20217:00 amRNSAcquisition of Valkor’s 50% interest in Greenfield
16th Aug 20217:00 amRNSNotice of AGM
30th Jul 202111:00 amRNSPrice Monitoring Extension
30th Jul 20219:05 amRNSSecond Price Monitoring Extn
30th Jul 20219:00 amRNSPrice Monitoring Extension
27th Jul 20217:00 amRNSReceipt of Final FEED Study and Third-Party Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.